NeutropeniaAgranulocytosisFebrile NeutropeniaFeverChemotherapy-Induced Febrile NeutropeniaGranulocyte Colony-Stimulating FactorAntineoplastic Combined Chemotherapy ProtocolsDrug Administration ScheduleTreatment OutcomeDelayed DiagnosisTaxoidsNeoplasmsEarly DiagnosisInfusions, IntravenousPaclitaxelPrenatal DiagnosisThrombocytopeniaRetrospective StudiesSensitivity and SpecificityCamptothecinLeukocyte CountMaximum Tolerated DoseDeoxycytidineAntineoplastic AgentsMycosesCisplatinAntineoplastic Agents, PhytogenicDiagnosisFelty SyndromeSurvival AnalysisLeukocyte ElastaseNeutrophilsFluorouracilLeukopeniaProspective StudiesFever of Unknown OriginHematologic DiseasesLung NeoplasmsSurvival RateTime FactorsVinblastineBacterial InfectionsDose-Response Relationship, DrugReceptors, Granulocyte Colony-Stimulating FactorCarboplatinOpportunistic InfectionsDisease-Free SurvivalCyclophosphamideDoxorubicinHematologic NeoplasmsNeoplasm StagingOrganoplatinum CompoundsPrognosisLeucovorinFollow-Up StudiesRisk FactorsBreast NeoplasmsTopotecanImmunocompromised HostDiagnostic ErrorsNauseaEtoposidePredictive Value of TestsTomography, X-Ray ComputedDisease ProgressionCombined Modality TherapyBlood Cell CountRecombinant ProteinsNeoplasm MetastasisBone MarrowBiopsyEpirubicinArea Under CurveAspergillosisAnti-Bacterial AgentsInfant, NewbornNeoplasm Recurrence, LocalAntifungal AgentsSalvage TherapyAdenocarcinomaAntimetabolites, AntineoplasticAdministration, OralSyndromeNursing DiagnosisDiagnosis, Computer-AssistedCarcinoma, Non-Small-Cell LungRecurrenceCohort StudiesRemission InductionReproducibility of ResultsDrug Therapy, CombinationIncidencePolymerase Chain ReactionOxonic AcidVincristineLymphoma, Non-HodgkinFatal OutcomeBacteremiaFungemiaIfosfamide